The aim of this review is to analyze and summarize the types, sites, and enzymes of tau PTMs and the mechanisms of abnormal tau protein accumulation that trigger AD, including mitochondrial dysfunction, synaptic plasticity impairments, and glia-mediated neuroinflammation. This evidence concerns the gene MAPT and Alzheimer disease.